Has Andrew Wassef, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,525,333 in general payments to Andrew Wassef, MD across 1,025 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Wassef, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Wassef, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Wassef, MD

Orthopaedic Surgery · Lakewood, CANPI 1982848099

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,039,893 of the $1,525,333 with a category attached, or 68.2%. Stryker accounts for 80.7% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $337,860, 2.3 times the $148,075 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,525,333in general payments, 2019–2025

Across 1,025 payments — averaging $1488.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$1.2M
Austin Medical Ventures Inc$251K
Heraeus Medical, LLC.$21K
Bone Support Inc.$19K
Zimmer Biomet$1K
KCI USA, Inc.$902
plus $1K from 13 others

$45,714in ownership & investment interests, 2019–2025

Across 1 payment — averaging $45,714 each. An ownership or investment interest held by the physician or an immediate family member.

Overture Orthopaedics$46K

What the payments were for

Royalty or licence$271,90118%
Consulting fees$1,039,89368%
Speaking & faculty fees$250%
Travel & lodging$191,04113%
Food & beverage$22,4541%
Entertainment$190%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	949	$1,231,033
Austin Medical Ventures Inc	10	$251,346
Heraeus Medical, LLC.	2	$20,984
Bone Support Inc.	16	$19,023
Zimmer Biomet	10	$1,008
KCI USA, Inc.	4	$902
Dynasplint Systems Inc.	1	$192
Next Science LLC	1	$172
Amgen	14	$162
Globus Medical	3	$107
Overture Orthopaedics	2	$84
Pacira Pharmaceuticals Incorporated	2	$67
Orthofix Medical, Inc.	1	$64
Smith+Nephew	3	$63
Bioventus LLC	2	$40
Johnson & Johnson	2	$30
Vertex	1	$23
ERMI LLC	1	$17
Pacira Therapeutics, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,525,333 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$467,604

Medicare patients

553

Services billed

8,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	37	$32,051
Celecoxib	133	$3,852
Lidocaine	22	$1,992
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	101	$1,516
Doxycycline Hyclate	20	$823
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	34	$484
Cephalexin	82	$317
Diclofenac Sodium	13	$308
Ibuprofen	33	$232
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	16	$159
Gabapentin	24	$152
Tramadol Hcl	37	$113
Methylprednisolone	18	$96
Meloxicam	63	$90
Ondansetron Hcl	11	$85

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Lakewood

Bradford HackArcadia$18.3M
Robert GorabOrange$13.6M
Kelly VinceLos Angeles$9.6M
Stephen HowellSacramento$9.4M
Thomas CoonRed Bluff$9.2M
Nirav AminPlacentia$5.6M
Tom NorrisSan Francisco$5.3M
Jay LiebermanLos Angeles$4.8M
Peter NewtonSan Diego$4.2M
Sigurd BervenSan Francisco$4.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →